Commission Implementing Regulation (EU) 2019/291 of 19 February 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-naphthylacetamide, 1-naphthylacetic acid, acrinathrin, azoxystrobin, fluazifop p, fluroxypyr, imazalil, kresoxim-methyl, oxyfluorfen, prochloraz, prohexadione, spiroxamine, tefluthrin and terbuthylazine (Text with EEA relevance.)
2019年2月19日委员会实施条例(EU)2019/291修订了第540/2011号实施条例(EU) 涉及延长活性物质1-萘乙酰胺、1-萘乙酸、吖啶菊酯、偶氮菌酯、氟唑磷、氟罗西吡酯、伊马扎利、甲基克雷索辛、氧氟芬、咪鲜胺、前己二酮、螺旋胺的批准期 特氟醚和特布他嗪(与欧洲经济区相关的文本 )
Commission Implementing Regulation (EU) 2019/291 of 19 February 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-naphthylacetamide, 1-naphthylacetic acid, acrinathrin, azoxystrobin, fluazifop p, fluroxypyr, imazalil, kresoxim-methyl, oxyfluorfen, prochloraz, prohexadione, spiroxamine, tefluthrin and terbuthylazine (Text with EEA relevance.)